PortfoliosLab logoPortfoliosLab logo
AVDL vs. PAA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVDL vs. PAA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avadel Pharmaceuticals plc (AVDL) and Plains All American Pipeline, L.P. (PAA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


AVDL

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

PAA

1D
0.88%
1M
4.97%
YTD
32.09%
6M
35.41%
1Y
42.03%
3Y*
29.12%
5Y*
22.64%
10Y*
5.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVDL vs. PAA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AVDL
Avadel Pharmaceuticals plc
0.42%105.04%-25.57%97.21%-11.39%20.96%-11.52%192.64%-68.54%-21.08%
PAA
Plains All American Pipeline, L.P.
32.09%14.30%21.38%39.18%35.79%22.24%-50.79%-2.28%2.31%-31.34%

Correlation

The correlation between AVDL and PAA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Nov 18, 1998

0.12

Fundamentals

Market Cap

AVDL:

$2.19B

PAA:

$16.10B

EPS

AVDL:

-$0.00

PAA:

$2.19

PS Ratio

AVDL:

8.72

PAA:

0.36

PB Ratio

AVDL:

22.31

PAA:

1.26

Total Revenue (TTM)

AVDL:

$248.52M

PAA:

$45.25B

Gross Profit (TTM)

AVDL:

$234.76M

PAA:

$1.55B

EBITDA (TTM)

AVDL:

$10.13M

PAA:

$2.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVDL vs. PAA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVDL

PAA
PAA Risk / Return Rank: 8787
Overall Rank
PAA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
PAA Sortino Ratio Rank: 9090
Sortino Ratio Rank
PAA Omega Ratio Rank: 8787
Omega Ratio Rank
PAA Calmar Ratio Rank: 8383
Calmar Ratio Rank
PAA Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVDL vs. PAA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and Plains All American Pipeline, L.P. (PAA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

AVDL vs. PAA - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


AVDLPAADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.85

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

Drawdowns

AVDL vs. PAA - Drawdown Comparison


Loading charts...

Drawdown Indicators


AVDLPAADifference

Max Drawdown

Largest peak-to-trough decline

-91.99%

Max Drawdown (1Y)

Largest decline over 1 year

-14.53%

Max Drawdown (3Y)

Largest decline over 3 years

-22.26%

Max Drawdown (5Y)

Largest decline over 5 years

-26.11%

Max Drawdown (10Y)

Largest decline over 10 years

-87.92%

Current Drawdown

Current decline from peak

-8.58%

Average Drawdown

Average peak-to-trough decline

-25.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.01%

Volatility

AVDL vs. PAA - Volatility Comparison


Loading charts...

Volatility by Period


AVDLPAADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.29%

Volatility (6M)

Calculated over the trailing 6-month period

14.05%

Volatility (1Y)

Calculated over the trailing 1-year period

18.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.83%

Dividends

AVDL vs. PAA - Dividend Comparison

AVDL has not paid dividends to shareholders, while PAA's dividend yield for the trailing twelve months is around 7.00%.


PositionTTM20252024202320222021202020192018201720162015
AVDL
Avadel Pharmaceuticals plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PAA
Plains All American Pipeline, L.P.
7.00%8.46%7.44%7.06%7.08%7.71%10.92%7.50%5.99%9.45%8.21%11.93%

Financials

AVDL vs. PAA - Financials Comparison

This section allows you to compare key financial metrics between Avadel Pharmaceuticals plc and Plains All American Pipeline, L.P.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
77.47M
12.47B
(AVDL) Total Revenue
(PAA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVDL and PAA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for AVDL and PAA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer